These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Advances in gene therapy for hemophilia: basis, current status, and future perspectives. Ohmori T Int J Hematol; 2020 Jan; 111(1):31-41. PubMed ID: 30083852 [TBL] [Abstract][Full Text] [Related]
24. [Haemophilia]. Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381 [TBL] [Abstract][Full Text] [Related]
25. Advances and challenges for hemophilia gene therapy. Batty P; Lillicrap D Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in developing specific therapies for haemophilia. Ling G; Nathwani AC; Tuddenham EGD Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795 [TBL] [Abstract][Full Text] [Related]
27. WFH State-of-the-art paper 2020: In vivo lentiviral vector gene therapy for haemophilia. Cantore A; Naldini L Haemophilia; 2021 Feb; 27 Suppl 3(Suppl 3):122-125. PubMed ID: 32537776 [TBL] [Abstract][Full Text] [Related]
28. Gene Therapy in Hemophilia: Recent Advances. Rodríguez-Merchán EC; De Pablo-Moreno JA; Liras A Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299267 [TBL] [Abstract][Full Text] [Related]
29. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
30. Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia A. Quade-Lyssy P; Abriss D; Milanov P; Ungerer C; Königs C; Seifried E; Schüttrumpf J J Thromb Haemost; 2014 Nov; 12(11):1861-73. PubMed ID: 25224783 [TBL] [Abstract][Full Text] [Related]
31. Hemophilia gene therapy comes of age. George LA Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):587-594. PubMed ID: 29222308 [TBL] [Abstract][Full Text] [Related]
32. New high-technology products for the treatment of haemophilia. Pipe SW; Saint-Remy JM; Walsh CE Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373 [TBL] [Abstract][Full Text] [Related]
33. A golden age for Haemophilia treatment? Makris M; Hermans C Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683 [No Abstract] [Full Text] [Related]
36. Human factor VIII can be packaged and functionally expressed in an adeno-associated virus background: applicability to haemophilia A gene therapy. Gnatenko DV; Saenko EL; Jesty J; Cao LX; Hearing P; Bahou WF Br J Haematol; 1999 Jan; 104(1):27-36. PubMed ID: 10027708 [TBL] [Abstract][Full Text] [Related]
37. The promise of third-generation recombinant therapy and gene therapy. Manno CS Semin Hematol; 2003 Jul; 40(3 Suppl 3):23-8. PubMed ID: 14690065 [TBL] [Abstract][Full Text] [Related]